face
Dr. Abraham Escobedo Moratilla

Gerente del Consorcio CIIDZA

Miembro del SNI, Nivel 1

Telefono: 8342000
Ext. :7323
Correo: abraham.escobedo@ipicyt.edu.mx

Selección de artículos de investigación


Publicaciones en el Science Citation Index

1.- Patiño-Rodríguez O, Escobedo-Moratilla A, Martínez-Medina RM, Torres-Roque I, Pérez-Urizar J, Martínez-Delgado M. Development and validation of a sensitive LC-MS/MS method for determination of betamethasone in human plasma. Application to a pharmacokinetic study of healthy mexican subjects . CURRENT PHARMACEUTICAL ANALYSIS .
14(00): 1-7

2.- Salcedo AL, Hernández-Domínguez E, de Luna LA, Guevara-Garcia AA, Escobedo-Moratilla A, Bojórquez-Velázquez E, del Rio-Portilla F, Fernández-Velasco DA, Barba de la Rosa AP Insights on structure and function of a late embryogenesis abundant protein from Amaranthus cruentus: An intrinsically disordered protein involved in protection against desiccation. FRONTIERS IN PLANT SCIENCE.
8: 497

3.- Patiño-Rodríguez O, Zapata-Morales JR, Escobedo-Moratilla A, Díaz de León-Cabrero M, Torres-Roque I, Pérez-Urizar J Determination of pinaverium bromide in human plasma by a sensitive and robust UPLC-MS/MS method and application to a pharmacokinetic study in mexican subjects. JOURNAL OF CHROMATOGRAPHIC SCIENCE.
1-6Número de citas: 2

Publicaciones en otros índices internacionales

1.- Escobedo-Moratilla Abraham, Vázquez-Elorza Ariel Retrospective Mexican model of research managing: challenges and perspectives. JOURNAL OF SOCIAL RESEARCHES.

6 : 16-24

2.- Adriana Muñoz-Talavera, Miguel Ángel Gómez-Lim, Luis A. Salazar-Olivo, Jörg Reinders, Katharina Lim, Abraham Escobedo-Moratilla, Alberto Cristian López-Calleja, María Cristina Islas-Carbajal, Ana Rosa Rincón-Sánchez Expression of the Biologically Active Insulin Analog SCI-57 in Nicotiana Benthamiana. FRONTIERS IN PHARMACOLOGY.

10:1335 : 1-19

3.- Escobedo-Moratilla A, Velarde-Salcedo AJ, Magaña-Hernández CV, Barrera-Pacheco A, Espitia-Rangel E, Herrera-Estrella A, Barba de la Rosa AP Amaranth protein improves lipid profile and insulin resistance in a diet-induced obese mice model. JOURNAL OF FOOD AND NUTRITION RESEARCH.

5(12) : 914-924

4.- Patiño-Rodríguez O, Martínez-Medina RM, Torres-Roque I, Martínez-Delgado M, Mares-García AS, Escobedo-Moratilla A, Covarrubias-Pinedo A, Arzola-Paniagua A, Herrera-Torres JL, Pérez-Urizar J Absence of a significant pharmacokinetic interaction between atorvastatin and fenofibrate: a randomized, crossover, study of a fixed-dose formulation in healthy Mexican subjects. FRONTIERS IN PHARMACOLOGY.

6(4) : 1-6 Número de citas: 5

5.- Pérez-Urizar J, Torres-Roque I, Torres-Tirado D, Zapata-Morales JR, Escobedo-Moratilla A, Covarrubias-Pinedo A, Mares-García AS, Patiño-Rodríguez O Comparative, open label, single dose clinical trial of bioavailability of formulation containing ambroxol, trimethoprim and sulfamethoxazole in healthy volunteers. INTERNATIONAL JOURNAL OF PHARMACEUTICAL, CHEMICAL AND BIOLOGICAL SCIENCES.

5(1) : 1-7

6.- Escobedo-Moratilla A, Barba de la Rosa AP, Pérez-Urizar JT Modelos preclínicos in vitro e in vivo para la evaluación de la actividad biológica en estudios de biocomparabilidad. GACETA MÉDICA MEXICANA.

151 : 377-86

7.- de Araujo Ferreira AA, Coelho Guerra GB, da Silva Solon LG, Dibildox E, Perez-Urizar J, Escobedo-Moratilla A, Torres-Roque I, Martinez-Delgado M, Zapata-Morales JR, Lira-Soares L, Covarrubias-Pinedo A Comparative bioavailability of two extemporaneous solid formulations of carbamazepine against the innovator in Mexican healthy subjects. JOURNAL OF BIOEQUIVALENCE AND BIOAVAILABILITY.

6(2) : 33-37 Número de citas: 1

8.- Patiño-Rodríguez O, Torres-Roque I, Martínez-Delgado M, Escobedo-Moratilla A, Pérez-Urizar J Pharmacokinetic non-interaction analysis in a fixed-dose formulation incombination of atorvastatin and ezetimibe. FRONTIERS IN PHARMACOLOGY.

5(261) : 1-9 Número de citas: 10


Cerrar